Cumbo Alexander

President and CEO, DirectorSolid Biosciences Inc. (SLDB) · full profile →Form 4 · filed Feb 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$517K
Net Open-Market Flow
-$517K
Transactions
7
3 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Sell(S)80K$6.44$517K271K
Jan 31, 2026Option exercise(M)100K351K
Jan 29, 2026Option exercise(M)169K251K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2026Option exercise(M)100K$0301K
Jan 29, 2026Grant(A)510K$0510K
Jan 29, 2026Grant(A)255K$0255K
Jan 29, 2026Option exercise(M)169K$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-034087) within minutes of acceptance. Every field above traces to the original document. Verify it directly: